Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00395291 · ClinicalTrials.gov registry record · NA
Growth Hormone Secretagogue MK-0677 Effect on IGF-1 Levels in ESRD Patients
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 49
- Enrollment target
NCT00395291 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 49 participants.
The verdict
NCT00395291, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
Study Summary
The objective of this study is to determine MK-0677 increases IGF-1 in patients with end stage renal disease (ESRD) on hemodialysis.
Interventions
- DRUG Placebo
- DRUG MK-0677
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2006-08 |
| Est. Completion | 2010-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00395291
The ClinicalTrials.gov registry entry for NCT00395291 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00395291 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00395291 about?
NCT00395291 is a clinical study titled "Growth Hormone Secretagogue MK-0677 Effect on IGF-1 Levels in ESRD Patients". The objective of this study is to determine MK-0677 increases IGF-1 in patients with end stage renal disease (ESRD) on hemodialysis.
What is the current status of trial NCT00395291?
This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2006-08. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00395291?
The interventions under investigation include: Placebo (DRUG), MK-0677 (DRUG).
Who is sponsoring clinical trial NCT00395291?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.